Elevation Oncology Inc

General ticker "ELEV" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $37.3M

Elevation Oncology Inc does not follow the US Stock Market performance with the rate: -23.5%.

Estimated limits based on current volatility of 6.5%: low 0.56$, high 0.64$

Factors to consider:

  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.31$, 1.13$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.44$, 1.42$]

Financial Metrics affecting the ELEV estimates:

  • Negative: Non-GAAP EPS, $ of -1.31 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -76.70 <= 2.35
  • Negative: negative Net income
  • Positive: Inventory ratio change, % of 0 <= 0
  • Positive: Interest expense per share, $ of 0.12 <= 0.14

Similar symbols

Short-term ELEV quotes

Long-term ELEV plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $32.05MM $94.55MM $45.45MM
Operating Income $-32.05MM $-94.55MM $-45.45MM
Non-Operating Income $0.01MM $-0.51MM $-0.23MM
Interest Expense $0.00MM $0.48MM $4.17MM
R&D Expense $23.59MM $78.72MM $25.43MM
Income(Loss) $-32.04MM $-95.06MM $-45.67MM
Taxes $0.00MM $0.03MM $0.03MM
Profit(Loss) $-32.04MM $-95.08MM $-45.70MM
Stockholders Equity $140.70MM $49.03MM $54.81MM
Assets $149.49MM $94.16MM $89.09MM
Operating Cash Flow $-30.17MM $-85.48MM $-56.18MM
Capital expenditure $0.00MM $0.09MM $0.00MM
Investing Cash Flow $0.00MM $-44.40MM $11.54MM
Financing Cash Flow $97.05MM $29.51MM $47.98MM
Earnings Per Share* $-1.38 $-4.09 $-1.34

* EPS are Split Adjusted, recent splits may be reflected with a delay.